This post was originally published on this site
https://i-invdn-com.investing.com/news/LYNXMPEB59082_M.jpg
The agreement is designed as an advance purchase deal, conditional on the World Health Organization’s (WHO) declaration of a flu pandemic. In such a scenario, Britain will have the right to procure these vaccines, thus facilitating a swift response to protect public health.
The vaccines involved in this agreement are produced at CSL’s manufacturing facility in Liverpool.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
